CliffBio
small molecule

ORAVIG

MICONAZOLE

Loss of exclusivity—loss of exclusivity
CompanyGalt Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameORAVIG
Active ingredientMICONAZOLE
Strength50MG
Dosage formTABLET
RouteBUCCAL
ModalitySmall molecule
FDA approvalApril 2010
Marketing statusRX

More from Galt Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ORAVIG patent cliff — loss of exclusivity — | CliffBio